Cite
Modeling SARS-CoV-2 antibody seroprevalence and its determinants in Ghana: A nationally representative cross-sectional survey.
MLA
Owusu Donkor, Irene, et al. “Modeling SARS-CoV-2 Antibody Seroprevalence and Its Determinants in Ghana: A Nationally Representative Cross-Sectional Survey.” PLOS Global Public Health, vol. 3, no. 5, May 2023, p. e0001851. EBSCOhost, https://doi.org/10.1371/journal.pgph.0001851.
APA
Owusu Donkor, I., Mensah, S. K., Dwomoh, D., Akorli, J., Abuaku, B., Ashong, Y., Opoku, M., Andoh, N. E., Sumboh, J. G., Ohene, S.-A., Owusu-Asare, A. A., Quartey, J., Dumashie, E., Lomotey, E. S., Odumang, D. A., Gyamfi, G. O., Dorcoo, C., Afatodzie, M. S., Osabutey, D., … Koram, K. A. (2023). Modeling SARS-CoV-2 antibody seroprevalence and its determinants in Ghana: A nationally representative cross-sectional survey. PLOS Global Public Health, 3(5), e0001851. https://doi.org/10.1371/journal.pgph.0001851
Chicago
Owusu Donkor, Irene, Sedzro Kojo Mensah, Duah Dwomoh, Jewelna Akorli, Benjamin Abuaku, Yvonne Ashong, Millicent Opoku, et al. 2023. “Modeling SARS-CoV-2 Antibody Seroprevalence and Its Determinants in Ghana: A Nationally Representative Cross-Sectional Survey.” PLOS Global Public Health 3 (5): e0001851. doi:10.1371/journal.pgph.0001851.